PVS ratio comparisons across different variables using box plots with statistical comparison annotations for TP(a), DOSE(b), Shunt(c), Anesthesia(d), and Sex(e). by Ruitian Song (11045127)

Impact of PTGIR agonist/antagonist on CP genes expression in THP-1: parental, PTGIR expressed or knocked-down. by Mohamad Karaky (8910497)

Subjects:

The stability of H9N2 M1 protein is increased by the replacement of T37 with A37. by Chenxi Wang (284364)

Subjects:

The decrease in the correlation between DNM density and divergence with increasing evolutionary divergence. by Thomas C. A. Smith (5028620)

Colony formation in canine cells treated with the autophagy inhibitor spautin-1, doxorubicin, or a combination, with spautin-1 applied pre-chemotherapy. by Courtney R. Schott (5904980)

Relationship between CgA level changes and clinical response. by Tiantian Tian (2735887)

“…<p>(A) Of the twenty-eight patients that received IP chemotherapy as the first-line treatment, sixteen of twenty-three with non-progressive disease (PR and SD) showed decreased or stable CgA levels; three out of five with progressive disease (PD) exhibited increased CgA levels. …”

Body and adrenal weights. by Jesús David Ayala-Rodríguez (17364296)

DNA Methylation in <i>Cosmc</i> Promoter Region and Aberrantly Glycosylated IgA1 Associated with Pediatric IgA Nephropathy by Qiang Sun (225630)

“…After treatment with IL-4, the levels of <i>Cosmc</i> DNA methylation and aberrantly glycosylated IgA1 in IgAN lymphocytes were remarkably higher than the other two groups (<i>P</i><0.0001) with more markedly decreased Cosmc mRNA content (<i>P</i><0.0001). …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”

Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

“…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”